A Phase 3, Randomized, Multicenter, Double-Blind, Placebo- and Active Comparator-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 in Subjects With Moderate-to-Severe Plaque Psoriasis

Project: Research

Project Details

StatusActive
Effective start/end date22/05/24 → 22/05/26

Keywords

  • clinical trial
  • Psoriasis
  • Dermatology

Clinical Trial Phase

  • Phase III (a & b)